September is Sepsis Awareness Month and Dr. Jim Russell, a Principal Investigator at the Centre for Heart Lung Innovation (HLI) at St. Paul’s Hospital, is being recognized as the world’s top expert in septic shock.
Researchers at St. Paul’s are involved in an international study to determine whether the Polycap (a single pill containing multiple medications) reduces the risk of cardiovascular disease events.
People living with osteoarthritis are at an increased risk of cardiovascular disease compared to the general population. the reason is not known but some preliminary research suggests that non-steroidal anti-inflammatory drugs (NSAIDS) could play a role.
Dr. Knight is the new Vice-President, Research & Academic Affairs, Providence Health Care, and President of the Providence Health Care Research Institute.
B.C. saw a significant 40 per-cent jump in infectious syphilis cases from 2015 to 2016 and 30- to 35-per cent from 2017 to 2018.
Learn how PHC researchers are helping respond to the overdose crisis through research, teaching and community engagement.
Researchers at the BC Centre for Excellence in HIV/AIDS (BC-CfE) at St. Paul’s Hospital are monitoring and evaluating the hepatitis C epidemic in BC. Research scientist Dr. Kate Salters shares the basics on hep C and explains what’s being done to eliminate the disease.
Drs. Liam Brunham, Simon Pimstone and Karin Humphries were all involved in this retrospective study.
Dr. Zachary Laksman, a specialist in heart-rhythm disorders at Providence Health Care and Principal Investigator with the Centre for Heart Lung Innovation, has been named a Recipient of Canada’s Top 40 Under 40 for 2019.
The funding will support the renewal of the CIHR Canadian HIV Trials Network (CTN), whose National Centre is based at St. Paul’s.